ECSP099691A - Composición anestésica nanoparticulada para la administración tópica - Google Patents
Composición anestésica nanoparticulada para la administración tópicaInfo
- Publication number
- ECSP099691A ECSP099691A EC2009009691A ECSP099691A ECSP099691A EC SP099691 A ECSP099691 A EC SP099691A EC 2009009691 A EC2009009691 A EC 2009009691A EC SP099691 A ECSP099691 A EC SP099691A EC SP099691 A ECSP099691 A EC SP099691A
- Authority
- EC
- Ecuador
- Prior art keywords
- topical administration
- nanoparticulated
- anesthetic composition
- anesthetic
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Composición anestésica nanoparticulada para administración tópica donde por lo menos un agente anestésico local está encapsulado en nanopartículas poliméricas. La presente invención también se refiere al uso de dichas nanopartículas poliméricas que comprenden por lo menos un agente anestésico local, en la preparación de una composición anestésica para la administración tópica sobre la piel o mucosas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0700832A BRPI0700832B8 (pt) | 2007-03-16 | 2007-03-16 | composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP099691A true ECSP099691A (es) | 2010-02-26 |
Family
ID=39765309
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2009009691A ECSP099691A (es) | 2007-03-16 | 2009-10-14 | Composición anestésica nanoparticulada para la administración tópica |
Country Status (15)
Country | Link |
---|---|
US (1) | US8568788B2 (es) |
EP (1) | EP2134334B1 (es) |
JP (1) | JP5496684B2 (es) |
AR (1) | AR065723A1 (es) |
BR (1) | BRPI0700832B8 (es) |
CL (1) | CL2008000728A1 (es) |
CO (1) | CO6220944A2 (es) |
EC (1) | ECSP099691A (es) |
ES (1) | ES2804466T3 (es) |
HU (1) | HUE051155T2 (es) |
MX (1) | MX2009009853A (es) |
PE (2) | PE20131337A1 (es) |
PL (1) | PL2134334T3 (es) |
PT (1) | PT2134334T (es) |
WO (1) | WO2008113144A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0913809B1 (pt) | 2008-10-02 | 2019-02-05 | Mylan Inc | método para produzir continuamente um laminado adesivo sensível á pressão multicamada |
BR102012022036B1 (pt) * | 2012-08-31 | 2019-10-01 | Biolab Sanus Farmacêutica Ltda. | Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso |
BR102014028009B1 (pt) | 2014-11-10 | 2023-04-18 | Universidade Federal De Pelotas | Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos |
US11452700B2 (en) | 2017-08-04 | 2022-09-27 | Eric Haas | Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles |
CN113244167B (zh) * | 2021-05-20 | 2022-11-29 | 河北科技大学 | 一种盐酸利多卡因凝胶及其制备方法 |
RU208882U1 (ru) * | 2021-08-25 | 2022-01-19 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" | Раневая атравматическая повязка для животных |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7713618L (sv) * | 1977-12-01 | 1979-06-02 | Astra Laekemedel Ab | Lokalanestetisk blandning |
FR2659554B1 (fr) * | 1990-03-16 | 1994-09-30 | Oreal | Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant. |
DE4120760A1 (de) * | 1991-06-24 | 1993-03-04 | 3 M Medica Gmbh | Traegersysteme fuer arzneimittel |
JPH09255565A (ja) * | 1996-03-26 | 1997-09-30 | Daikyo Yakuhin Kogyo Kk | 皮膚局所麻酔用ヒドロゲルパッチ |
US6248345B1 (en) | 1997-07-02 | 2001-06-19 | Euro-Celtique, S.A. | Prolonged anesthesia in joints and body spaces |
US5993836A (en) * | 1998-04-28 | 1999-11-30 | Castillo; James G. | Topical anesthetic formulation |
KR100463167B1 (ko) * | 2001-04-13 | 2004-12-23 | 주식회사 태평양 | 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물 |
US20070154527A1 (en) * | 2001-10-12 | 2007-07-05 | Monosoirx, Llc | Topical film compositions for delivery of actives |
WO2006002365A2 (en) * | 2004-06-24 | 2006-01-05 | Angiotech International Ag | Microparticles with high loadings of a bioactive agent |
WO2006047279A2 (en) * | 2004-10-21 | 2006-05-04 | University Of Iowa Research Foundation | In situ controlled release drug delivery system |
WO2006091719A2 (en) * | 2005-02-23 | 2006-08-31 | Sontra Medical Corporation | Compositions and methods enhancing transdermal delivery of drugs and biologics |
-
2007
- 2007-03-16 BR BRPI0700832A patent/BRPI0700832B8/pt active IP Right Grant
-
2008
- 2008-03-12 EP EP08714517.3A patent/EP2134334B1/en active Active
- 2008-03-12 JP JP2009553872A patent/JP5496684B2/ja active Active
- 2008-03-12 PT PT87145173T patent/PT2134334T/pt unknown
- 2008-03-12 CL CL200800728A patent/CL2008000728A1/es unknown
- 2008-03-12 PL PL08714517T patent/PL2134334T3/pl unknown
- 2008-03-12 US US12/531,404 patent/US8568788B2/en active Active
- 2008-03-12 ES ES08714517T patent/ES2804466T3/es active Active
- 2008-03-12 MX MX2009009853A patent/MX2009009853A/es active IP Right Grant
- 2008-03-12 WO PCT/BR2008/000070 patent/WO2008113144A1/en active Application Filing
- 2008-03-12 HU HUE08714517A patent/HUE051155T2/hu unknown
- 2008-03-13 PE PE2013000512A patent/PE20131337A1/es active IP Right Grant
- 2008-03-13 AR ARP080101035A patent/AR065723A1/es not_active Application Discontinuation
- 2008-03-13 PE PE2008000474A patent/PE20081883A1/es not_active Application Discontinuation
-
2009
- 2009-10-14 EC EC2009009691A patent/ECSP099691A/es unknown
- 2009-10-14 CO CO09114245A patent/CO6220944A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0700832B8 (pt) | 2021-05-25 |
US8568788B2 (en) | 2013-10-29 |
AR065723A1 (es) | 2009-06-24 |
EP2134334A1 (en) | 2009-12-23 |
CL2008000728A1 (es) | 2008-09-26 |
EP2134334A4 (en) | 2013-04-24 |
CO6220944A2 (es) | 2010-11-19 |
ES2804466T3 (es) | 2021-02-08 |
BRPI0700832B1 (pt) | 2017-12-26 |
EP2134334B1 (en) | 2020-05-13 |
PT2134334T (pt) | 2020-08-20 |
MX2009009853A (es) | 2010-02-18 |
BRPI0700832A (pt) | 2008-11-04 |
PE20081883A1 (es) | 2008-12-27 |
JP2010521498A (ja) | 2010-06-24 |
PE20131337A1 (es) | 2013-11-18 |
JP5496684B2 (ja) | 2014-05-21 |
HUE051155T2 (hu) | 2021-03-01 |
WO2008113144A1 (en) | 2008-09-25 |
US20100086614A1 (en) | 2010-04-08 |
PL2134334T3 (pl) | 2021-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP099691A (es) | Composición anestésica nanoparticulada para la administración tópica | |
CR20130684A (es) | Composición limpiadora que comprende un agente gelificante y un tensioactivo empumante | |
CL2008000893A1 (es) | Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal. | |
CL2017002549A1 (es) | Uso de una composición de bismuto-tiol (bt), que sirve para preparar un medicamento útil para el tratamiento de una herida abierta que tiene o que está en riesgo de tener una infección de biopelícula bacteriana. | |
UY28662A1 (es) | Agente endoparasiticida para administracion topica | |
BR112015019657A2 (pt) | composições tópicas e métodos de uso das mesmas | |
CL2008000897A1 (es) | Sal de arginina y uno o mas ácidos conjugados; composición de cuidado oral que comprende dicha sal; uso para reducir o inhibir la formacion de caries, desmineralizacion de los dientes; reducir la hipersensibilidad de los dientes, reducir o inhibir la gingivitos entre otras. | |
BRPI0921002A8 (pt) | Composições para tratamento bucal compreendendo sílica fundida e seu uso | |
BRPI0906197B8 (pt) | forma de administração em formato de tira | |
CL2015001984A1 (es) | (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
UY31765A (es) | Dihidropirazolonas sustituidas y su uso | |
UY33396A (es) | 5-fluoro-1h-pirazolopiridinas sustituidas y su uso | |
ECSP10010548A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
CL2008001756A1 (es) | Agente de arn de interferencia (iarn); composicion farmaceutica que lo comprende; y su uso para tratar procesos patologicos mediados al menos en parte por la expresion del canal de sodio epitelial alfa (alfa-enac) | |
AR074841A1 (es) | Composicion que comprende aceite de canamo para tratar enfermedades topicas, especialmente el sindrome mano-pie | |
CL2011000135A1 (es) | Uso de una fromulacion farmaceutica acuosa que comprende 0,5-10% de terbinafina o una sal de la misma, 2-10% de un fosfolipido y 1-5% de un surfactante, para preparar un medicamento util para tratar una infeccion fungica; formulacion farmaceutica. | |
BRPI0814446A2 (pt) | Uso de ácido hialurônico para o preparo de composições destinadas a melhorar notadamente a função de proteção da pele, de olho e das mucosas | |
UY31106A1 (es) | Formulaciones que contienen triazinonas y hierro | |
DOP2007000043A (es) | Derivados de cromanol sustituidos y su uso | |
ECSP109960A (es) | Gel conteniendo pirfenidona | |
NI201000189A (es) | Formulación de medicamento sólido con liberación retardadas. | |
BR112015010392A2 (pt) | composição para tratamento de pele | |
AR097599A1 (es) | Una composición que comprende extracto de guaçatonga y aroeira, su uso y un método para la prevención y/o tratamiento de señales causadas por el envejecimiento de la piel | |
CO6660486A2 (es) | Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea |